Clean Air Plan update
This article was originally published in The Rose Sheet
Executive Summary
California Air Resources Board will postpone review of the Clean Air Plan to provide more time for public comment, CARB says in 1March 25 announcement. Public comments will be accepted until May 15, as board consideration, originally scheduled for CARB's April 25-26 meeting, will be rescheduled for a later date, agency adds. Technical workshop slated for early April also will be moved to a later date. Developed by CARB staff, Clean Air Plan aims to reduce reactive gas emissions, including those generated from voluntary organic compounds found in personal care products (2"The Rose Sheet" March 25, 2002, p. 3)...
You may also be interested in...
CARB VOC Limits In Additional Personal Care Categories Outlined In Plan
The California Air Review Board should consider evaluating additional personal care product categories for possible reductions in reactive organic gas emissions, according to a proposed comprehensive Clean Air Plan released March 15
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.